prescription pills

Kmart Corporation to Pay U.S. $32.3 Million to Resolve False Claims Act Allegations for Overbilling Federal Health Programs for Generic Prescription Drugs

Kmart Corporation, a wholly owned subsidiary of Sears Holdings Corporation (SHC), has agreed to pay $32.3 million to the United States to settle allegations that in-store pharmacies in Kmart stores failed to report discounted prescription drug prices to Medicare Part D, Medicaid, and TRICARE. The False Claims Act lawsuit, which was filed in 2008 by...
Continue reading…

Consumer Watchdog Group Sues Novartis and GlaxoSmithKline for allegedly false statements on Voltaren to treat osteoarthritis

An Australian Consumer Watchdog Agency Says Misleading Claims Will Ultimately Hurt the Public An Australian Consumer Watchdog group is taking two big pharmaceutical companies to court. The Australian Competition and Consumer Commission says that Novartis (NVS) and GlaxoSmithKline (GSK) are making false claims about a topical gel and pocketing the profits. Misleading the Public According to...
Continue reading…

S.E.C. charges Provectus Biopharmaceutical Co. for failing to reveal millions in CEO CFO perks

The Securities and Exchange Commission charged ProvectusŒ biopharmaceutical company with failure to properly report as compensation millions of dollars in perks provided to its then-CEO and then-CFO. According to the SEC, Provectus lacked sufficient controls surrounding the reporting and disclosure of travel and entertainment expenses submitted by its executives. The order further finds that...
Continue reading…

Three drug makers use nurses in scheme to promote diabetes meds to docs say lawsuits

According to the publication STAT, a Boston Globe publication, three more drug makers have allegedly relied on fraudulent schemes where which nurses were used to illegally promote its diabetes medicines to physicians. The information comes from three unsealed lawsuits filed by whistleblowers under the False Claims Act.  The lawsuits allege that Gilead Sciences,...
Continue reading…